The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.514
Bid: 1.518
Ask: 1.528
Change: 0.002 (0.13%)
Spread: 0.01 (0.659%)
Open: 1.52
High: 1.53
Low: 1.51
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB's Yer-end Seperate Financial Statements

1 Feb 2018 07:00

RNS Number : 5610D
Commercial Intnl Bank (Egypt) SAE
01 February 2018
 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

Year End , 2017

 

 

FINANCIAL POSITION

As of December 31st , 2017

Amounts in EGP Thousands

Note

December 31, 2017

 

December 31, 2016

 

Assets

Cash and balances with central bank

15

14,663,289

10,522,040

Due from banks

16

45,319,766

58,011,034

Treasury bills and other governmental notes

17

54,478,202

39,177,184

Trading financial assets

18

7,295,197

2,445,134

Loans and advances to banks, net

19

1,313

159,651

Loans and advances to customers, net

20

88,427,103

85,991,914

Derivative financial instruments

21

40,001

269,269

Financial investments

- Available for sale

22

30,474,781

5,447,291

- Held to maturity

22

45,167,722

53,924,936

Investments in associates and subsidiaries

23

54,068

10,500

Non current assets held for sale

42

-

428,011

Other assets

24

6,886,807

5,446,025

Intangible assets

41

368,923

499,131

Deferred tax assets (Liabilities)

32

179,630

181,308

Property, plant and equipment

25

1,414,519

1,338,629

Total assets

294,771,321

263,852,057

Liabilities and equity

Liabilities

Due to banks

26

1,877,918

3,008,996

Due to customers

27

250,767,370

231,965,312

Derivative financial instruments

21

196,984

331,091

Current tax liabilities

2,778,973

2,017,034

Other liabilities

29

5,476,531

3,579,330

Long term loans

28

3,674,736

160,243

Other provisions

30

1,615,159

1,514,057

Total liabilities

266,387,671

242,576,063

Equity

Issued and paid up capital

31

11,618,011

11,538,660

Reserves

34

8,725,966

3,443,319

Reserve for employee stock ownership plan (ESOP)

489,334

343,460

Total equity

20,833,311

15,325,439

Net profit for the period/year

7,550,339

5,950,555

Total equity and net profit for the period/ year

28,383,650

21,275,994

Total liabilities and equity

294,771,321

263,852,057

INCOME STATEMENT

As of December 31st , 2017

Amounts in EGP Thousands

Note

December 31, 2017

 

December 31, 2016

 

Interest and similar income

28,671,170

19,144,218

Interest and similar expense

(16,167,155)

(9,126,512)

Net interest income

6

12,504,015

10,017,706

Fee and commission income

2,676,944

1,965,529

Fee and commission expense

(624,278)

(417,573)

Net fee and commission income

7

2,052,666

1,547,956

Dividend income

8

34,514

34,236

Net trading income

9

1,292,215

1,315,182

Profits on financial investments

22

496,045

32,121

Administrative expenses

10

(3,112,508)

(2,432,652)

Other operating (expenses) income

11

(1,063,468)

(1,237,187)

Goodwill impairment

-

(209,842)

Intangible assets amortization

41

(130,208)

(130,208)

Impairment charge for credit losses

12

(1,742,281)

(892,874)

Profit before income tax

10,330,990

8,044,438

Income tax expense

13

(2,778,973)

(2,017,034)

Deferred tax assets (Liabilities)

32 & 13

(1,678)

(76,849)

Net profit for the Period

7,550,339

5,950,555

Earnings per share

14

Basic

5.76

4.54

Diluted

5.67

4.47

CASH FLOW STATEMENT

As of December 31st , 2017

 

 

 

Amounts in EGP Thousands

 

December 31, 2017

December 31, 2016

Cash flow from operating activities

Profit before income tax

10,330,990

8,044,438

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

351,005

285,381

Impairment charge for credit losses

1,742,281

892,874

Other provisions charges

212,622

150,847

Trading financial investments revaluation differences

(248,072)

(269,283)

Available for sale and held to maturity investments exchange revaluation differences

100,078

(2,219,961)

Goodwill impairment

-

209,842

Intangible assets amortization

130,208

130,208

Financial investments impairment charge

(83,079)

82,428

Utilization of other provisions

(25,463)

(3,696)

Other provisions no longer used

(97,897)

(78,405)

Exchange differences of other provisions

11,840

583,550

Profits from selling property, plant and equipment

(607)

(1,682)

Profits from selling financial investments

99,047

(35,193)

Profits (losses) from selling associates

-

32,793

Shares based payments

290,884

187,000

Impairment (Released) charges of non-current assets held for sale

(340,504)

(131,799)

 

Operating profits before changes in operating assets and liabilities

 

12,473,333

7,859,342

Net decrease (increase) in assets and liabilities

Due from banks

(2,594,442)

264,072

Treasury bills and other governmental notes

(16,466,420)

(16,057,258)

Trading financial assets

(4,601,991)

3,672,526

Derivative financial instruments

95,161

(2,918)

Loans and advances to banks and customers

(4,019,132)

(29,833,291)

Other assets

(1,121,981)

(599,879)

Non-Current Assets Held for Sale

428,011

-

Due to banks

(1,131,078)

1,408,227

Due to customers

18,802,058

76,595,390

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

1,897,201

957,061

Net cash provided from operating activities

1,743,686

42,313,578

Cash flow from investing activities

Proceeds from redemption of subsidiary and associates

750

-

Payment ( proceeds) for purchases and sell of subsidiary and associates

(44,318)

176,161

Payment for purchases of property, plant, equipment and branches constructions

(745,089)

(560,631)

Proceeds from redemption of held to maturity financial investments

13,354,468

4,094

Payment for purchases of held to maturity financial investments

(4,597,254)

(1,243,669)

Payment for purchases of available for sale financial investments

(25,868,230)

(3,334,122)

Proceeds from selling available for sale financial investments

973,963

2,946,710

Proceeds from selling non current assets held for sale

628,521

-

Net cash used in investing activities

(16,297,189)

(2,011,457)

Cash flow from financing activities

Increase (decrease) in long term loans

3,514,493

28,915

Dividend paid

(1,350,204)

(1,463,450)

Capital Increase

79,351

68,057

Net cash used in financing activities

2,243,640

1,366,478

 

Net increase (decrease) in cash and cash equivalent during the period

(12,309,863)

38,935,643

Beginning balance of cash and cash equivalent

61,518,700

22,583,057

Cash and cash equivalent at the end of the period

49,208,837

61,518,700

Cash and cash equivalent comprise:

Cash and balances with central bank

14,663,289

10,522,040

Due from banks

45,319,766

58,011,034

Treasury bills and other governmental notes

54,478,202

39,177,184

Obligatory reserve balance with CBE

(8,878,986)

(5,438,235)

Due from banks with maturities more than three months

(1,719,586)

(2,565,895)

Treasury bills with maturity more than three months

(54,653,848)

(38,187,428)

Total cash and cash equivalent

49,208,837

61,518,700

 

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

 

Separate statement of changes in shareholders' equity for the period ended December 31, 2016

Dec. 31, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Net profit for the year

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

-

4,640,718

248,148

16,511,613

Capital increase

68,057

-

-

-

-

-

-

-

-

68,057

Transferred to reserves

-

232,008

3,035,878

564

-

-

-

(3,176,762)

(91,688)

-

Dividend paid

-

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

Net profit for the year

-

-

-

-

-

-

-

5,950,555

-

5,950,555

Net unrealised gain/(loss) on AFS

-

-

-

-

22,219

-

-

-

-

22,219

Transferred (from) to bank risk reserve

-

-

-

-

-

506

-

(506)

-

-

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

187,000

187,000

Balance at the end of the year

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

-

5,950,555

343,460

21,275,994

 

 

 

Separate statement of changes in shareholders' equity for the period ended December 31, 2017

 

 

 

 

Dec. 31, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

IFRS 9 risk reserve

Net profit for the year

Reserve for employee stock ownership plan

Total

 

 

EGP Thousands

 

 

Beginning balance

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

-

5,950,555

343,460

21,275,994

 

 

Capital increase

79,351

-

-

-

-

-

-

-

-

79,351

 

 

Transferred to reserves

-

297,444

4,445,620

1,682

-

-

-

(4,599,736)

(145,010)

-

 

 

Dividend paid

-

-

-

-

-

-

-

(1,350,204)

-

(1,350,204)

 

 

Net profit for the year

-

-

-

-

-

-

-

7,550,339

-

7,550,339

 

 

Net unrealised gain/(loss) on AFS

-

-

-

-

537,286

-

-

-

-

537,286

 

 

Transferred (from) to bank risk reserve

-

-

-

-

-

615

-

(615)

-

-

 

 

IFRS 9 risk reserve

-

-

-

-

-

-

1,411,549

(1,411,549)

-

-

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

290,884

290,884

 

 

Balance at the end of the year

11,618,011

1,332,807

9,000,023

32,460

(1,642,958)

3,634

1,411,549

6,138,790

489,334

28,383,650

 

 

 

 

Proposed appropriation account for the year ended December 31, 2017

Dec. 31, 2017

Dec. 31, 2016

EGP Thousands

EGP Thousands

Net profit after tax

7,550,339

5,950,555

Profits selling property, plant and equipment transferred to capital reserve according to the law

(607)

(1,682)

Bank risk reserve

(689)

(615)

Available net profit for distributing

7,549,043

5,948,258

IFRS 9 risk reserve*

(1,411,549)

-

Total

6,137,494

5,948,258

To be distributed as follows:

Legal reserve

377,487

297,444

General reserve

3,616,830

4,300,607

Dividends to shareholders

1,161,801

576,933

Staff profit sharing

754,904

594,826

Board members bonus

113,236

89,224

CIB's foundation

113,236

89,224

Total

6,137,494

5,948,258

*

The IFRS 9 risk reserve is created to comply with the Central Bank of Egypt instructions received on January 28, 2017.

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/5610D_-2018-1-31.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FKDDBBBKBPDN
Date   Source Headline
22nd Feb 20227:00 amRNSCIB FY 2021 Consolidated Financial Results
22nd Feb 20227:00 amRNSCIB FY2021 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Separate Condensed Financial Results
12th Nov 20217:00 amRNSCIB 3Q21 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB1H2021 Earnings Release
13th Jul 20217:00 amRNSCIB1H2021 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB 1H2021 Condensed Separate Financial Results
24th Jun 20213:43 pmRNSRelease re the change of title of Mr.Hussein Abaza
24th May 20217:00 amRNSCIB 1st Quarter Separate Financial Results
24th May 20217:00 amRNSCIB 1st Quarter Consolidated Financial Results
24th May 20217:00 amRNSCIB 1Q2021 Earnings Release
29th Apr 202110:09 amRNSCIB FY2020 Annual Financial Report
31st Mar 20215:28 pmRNSResolutions of CIB ordinary GAM held on March 30
8th Mar 20218:24 amRNSInvitation to CIB OrdinaryGeneral Assembly Meeting
8th Mar 20217:00 amRNSRelease regarding a change in CIB's BOD Structure
1st Mar 20217:00 amRNSCIB FY20 Consolidated Results
1st Mar 20217:00 amRNSCIB FY20 Year End Separate Financial Results
1st Mar 20217:00 amRNSCIB FY20 Year End Earnings Release
16th Dec 20207:00 amRNSCIB 3rd Quarter Separate Condensed Results
16th Dec 20207:00 amRNSCIB 3rd Quarter Consolidated Condensed Results
16th Dec 20207:00 amRNSCIB 3Q20 Earnings Release
16th Nov 20207:00 amRNSCIB Release on November 15th,2020
27th Oct 20202:28 pmRNSCIB's Press Release dated October 27th, 2020
23rd Oct 20203:59 pmRNSCIB Press Release
12th Oct 20204:13 pmRNSRelease concerning changes in CIB'sBoard Structure
22nd Sep 20202:33 pmRNSRelease on change in Board of Directors Structure
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSCIB First Half 2020 Earnings Release
14th Jul 20207:00 amRNSCIB Consolidated Interim Condensed June Statements
14th Jul 20207:00 amRNSCIB Interim Separate Condensed June Statements
1st Jul 20201:04 pmRNSRelease on Subordinated debt from CDC
5th May 20207:00 amRNSCIB reports 1Q20 Earning Release
5th May 20207:00 amRNSCIB 1st Quarter Consolidated Results
5th May 20207:00 amRNSCIB 1st Quarter Separate Results
28th Apr 20207:00 amRNSCIB Year End 2019 IFRS Consolidated Results
27th Apr 20207:00 amRNSCIB acquires 51% of Mayfair Bank in Kenya
30th Mar 20209:00 amRNSRelease on CEO self-quarantine
24th Mar 202012:02 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSCIB's EGM Resolutions (March 15th 2020)
16th Mar 20207:00 amRNSCIB's AGM Resolutions (March 15th 2020)
20th Feb 20202:39 pmRNSItems to be discussed in EGM of March 15th, 2020
20th Feb 20202:37 pmRNSItems to be discussed in AGM of March 15th, 2020
18th Feb 20202:31 pmRNSInvitation to CIB Extraordinary GAM
18th Feb 20202:29 pmRNSInvitation toCIB Ordinary General Assembly Meeting
4th Feb 20207:00 amRNSFY 2019 Separate Financial Results
4th Feb 20207:00 amRNSFY 2019 Earnings Release
4th Feb 20207:00 amRNSFY 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB 3Q 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB Separate 3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.